The renal clearance of free and peptide-bound deoxypyridinoline: Response to pamidronate treatment of Paget's disease

Journal of Bone and Mineral Research

Volumn 18, Issue 4, 2003, Pages 658-661

  Naylor, Ke ^a   Jackson, B ^a   Eastell, Richard ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bisphosphonate; Deoxypyridinoline; Kidney; Paget's disease

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DEOXYPYRIDINOLINE; ESTROGEN; PAMIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY; KIDNEY CLEARANCE; MALE; PAGET BONE DISEASE; PROTEIN BINDING; URINE LEVEL;

AGED; AGED, 80 AND OVER; AMINO ACIDS; COLLAGEN; CROSS-LINKING REAGENTS; DIPHOSPHONATES; FEMALE; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEITIS DEFORMANS; PEPTIDES; PROTEIN BINDING;

EID: 0042807414     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.4.658     Document Type: Article

References (14)

1. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ 1991 Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 21:310-315.
2. Eastell R, Colwell A, Hampton L, Reeve J 1997 Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res 12:59-65.
3. Seibel MJ, Woitge H, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, Ziegler R, Robins SP 1994 Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot study. J Bone Miner Res 9:1433-1440.
4. Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L 1996 Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 11:1176-1184.
5. Colwell A, Eastell R 1996 The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 11: 1976-1980.
6. Rucklidge GJ, Riddoch GT, Williams LM, Robins SP 1988 Autoradiographic studying of the renal clearance of circulating type 1 collagen fragments in the rat. Collagen Res 8:339-348.
7. Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ 1999 Novel serum markers of bone resorption: Clinical assessment and comparison with established urinary indices. J Bone Miner Res 14:792-801.
8. Blumsohn A, Naylor K, Assiri AM, Eastell R 1995 Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin Chem 41:1592-1598.
9. Gamero P, Gineyts E, Arbault P, Christiansen C, Delmas PD 1995 Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 10:641-649.
10. Colwell A, Russell RG, Eastell R 1993 Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 23:341-349.
11. Hannon R, Blumsohn A, Naylor K, Eastell R 1998 Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability. J Bone Miner Res 13: 1124-1133.
12. Clemens JD, Herrick MV, Singer FR, Eyre DR 1997 Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43:2058-2063.
13. Apone S, Lee MY, Eyre DR 1997 Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone. Bone 21:129-136.
14. Eyre DR 1995 The specificity of collagen cross-links as markers of bone and connective tissue degradation. Acta Orthop Scand 66: 166-170.